BALFAXAR
Biological
Octapharma USA, Inc.
Total Payments
$49,885
Transactions
307
Doctors
214
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $42,080 | 268 | 184 |
| 2023 | $7,805 | 39 | 30 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $37,287 | 12 | 74.7% |
| Food and Beverage | $8,722 | 276 | 17.5% |
| Travel and Lodging | $3,081 | 15 | 6.2% |
| Unspecified | $500.00 | 1 | 1.0% |
| Consulting Fee | $295.00 | 3 | 0.6% |
Payments by Type
General
$49,385
306 transactions
Research
$500.00
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LEX-210 | Octapharma USA, Inc. | $500.00 | 0 |
Top Doctors Receiving Payments for BALFAXAR — Page 9
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , FNP | Emergency | Shelbyville, TN | $16.39 | 1 |
| , MD | Anesthesiology | Jacksonville, FL | $15.98 | 1 |
| , M.D | Anesthesiology | Leesburg, FL | $15.98 | 1 |
| , NP | Nurse Practitioner | Rockford, IL | $15.11 | 1 |
| , M.D | Internal Medicine | Roxboro, NC | $14.15 | 1 |
| , APRN | Nurse Practitioner | Chattanooga, TN | $13.90 | 1 |
| , M.D | Emergency Medicine | Memphis, TN | $13.77 | 1 |
| Daniel Poor | Emergency Medicine | Memphis, TN | $13.77 | 1 |
| , MD | Emergency Medicine | Chattanooga, TN | $13.76 | 1 |
| Zaza Cohen | Critical Care Medicine | Montclair, NJ | $13.66 | 1 |
| , MD | Emergency Medicine | Manahawkin, NJ | $13.63 | 1 |
| , MD | Emergency Medicine | Chattanooga, TN | $13.52 | 1 |
| , M.D | Emergency Medicine | Chattanooga, TN | $13.43 | 1 |
| Kyle Disney | Critical Care Medicine | Boca Raton, FL | $13.39 | 1 |
| , DO | Emergency Medicine | Seattle, WA | $13.16 | 1 |
Ad
Manufacturing Companies
- Octapharma USA, Inc. $49,885
Product Information
- Type Biological
- Total Payments $49,885
- Total Doctors 214
- Transactions 307
About BALFAXAR
BALFAXAR is a biological associated with $49,885 in payments to 214 healthcare providers, recorded across 307 transactions in the CMS Open Payments database. The primary manufacturer is Octapharma USA, Inc..
Payment data is available from 2023 to 2024. In 2024, $42,080 was paid across 268 transactions to 184 doctors.
The most common payment nature for BALFAXAR is "Honoraria" ($37,287, 74.7% of total).
BALFAXAR is associated with 1 research study, including "LEX-210" ($500.00).